IN2013MU01313A - - Google Patents

Info

Publication number
IN2013MU01313A
IN2013MU01313A IN1313MU2013A IN2013MU01313A IN 2013MU01313 A IN2013MU01313 A IN 2013MU01313A IN 1313MU2013 A IN1313MU2013 A IN 1313MU2013A IN 2013MU01313 A IN2013MU01313 A IN 2013MU01313A
Authority
IN
India
Prior art keywords
mixture
water
present
purification
norethindrone
Prior art date
Application number
Other languages
English (en)
Inventor
Amit Madanrao Agarkar
Himanshu Madhav Godbole
Girij Pal Singh
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Priority to IN1313MU2013 priority Critical patent/IN2013MU01313A/en
Priority to PCT/IB2014/059994 priority patent/WO2014162230A1/en
Publication of IN2013MU01313A publication Critical patent/IN2013MU01313A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
IN1313MU2013 2013-04-04 2014-03-20 IN2013MU01313A (sv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN1313MU2013 IN2013MU01313A (sv) 2013-04-04 2014-03-20
PCT/IB2014/059994 WO2014162230A1 (en) 2013-04-04 2014-03-20 Process for the purification of norethindrone and norethindrone acetate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1313MU2013 IN2013MU01313A (sv) 2013-04-04 2014-03-20

Publications (1)

Publication Number Publication Date
IN2013MU01313A true IN2013MU01313A (sv) 2015-04-10

Family

ID=50390155

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1313MU2013 IN2013MU01313A (sv) 2013-04-04 2014-03-20

Country Status (2)

Country Link
IN (1) IN2013MU01313A (sv)
WO (1) WO2014162230A1 (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111875656A (zh) * 2020-06-23 2020-11-03 浙江神洲药业有限公司 一种炔诺酮醋酸酯的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2744122A (en) 1951-11-22 1956-05-01 Syntex Sa delta 4-19-nor-17alpha-ethinylandrosten-17beta-ol-3-one and process
US2964537A (en) 1956-06-16 1960-12-13 Schering Ag Therapeutically valuable carboxylic acid esters of 17-alkyl-19-nor-testosterone
US3409643A (en) 1966-03-11 1968-11-05 Schering Corp Process for the preparation of 17alpha-alkynl-17beta-alkanoyloxy steroids of the androstane and estrane series
US3408371A (en) 1966-06-16 1968-10-29 Syntex Corp Esterification of 17alpha-ethinyl-17beta-hydroxy steroids
AT314098B (de) 1970-06-13 1974-03-25 Schering Ag Verfahren zur Äthinylierung von 17-Ketosteroiden
GB1399162A (en) * 1972-06-29 1975-06-25 Schering Ag 6-keto-delta1,3,5-10-steroids and process for the manufacture of 6-keto-delta1,3,5-10-steroids
DK136729C (da) * 1974-10-18 1978-05-01 Schering Ag Analogifremgangsmaade til fremstilling af 1alfa,17beta-dihydroxy-17beta-alkynyl-4-oestren-3-oner
US4244949A (en) * 1978-04-06 1981-01-13 The Population Council, Inc. Manufacture of long term contraceptive implant
DD295637A5 (de) * 1981-09-07 1991-11-07 Jenapharm Gmbh Jena,De Verfahren zur reinigung von steroiden
US4826689A (en) * 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds

Also Published As

Publication number Publication date
WO2014162230A1 (en) 2014-10-09

Similar Documents

Publication Publication Date Title
PH12018501159A1 (en) Composition and methods for immunooncology
AU2024202215A1 (en) Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia
PH12018501378A1 (en) Compositions and methods for the treatment of hemoglobinopathies
PH12017501042A1 (en) Anti-cd38 antibodies for treatment of acute myeloid leukemia
MX369645B (es) Anticuerpos multiespecificos.
EP3207977A4 (en) Exhaust gas purification apparatus
EP3133257A4 (en) Exhaust gas purification system
IN2014DN08481A (sv)
MX370649B (es) Proceso para la preparacion de teneligliptina.
NZ711192A (en) Process for making benzoxazepin compounds
IN2013MU00848A (sv)
SG11201609875UA (en) Process for the production of dimethyl ether from gaseous mixtures of carbon monoxide, hydrogen and methyl acetate
IN2013MU00646A (sv)
MX2015001506A (es) Proceso e intermediarios para preparar inhibidores de integrasa.
MY189993A (en) Process for catalytic preparation of aldehydes from olefins using monophosphite mixtures
IN2013MU03070A (sv)
NZ720106A (en) A process for the preparation of regadenoson
EP3328520A4 (en) POLYIMIDE MEMBRANE WITH HIGH SELECTIVITY FOR NATURAL GAS FINISHING AND HYDROGEN CLEANING
ZA201806956B (en) Catalyst mixture for the treatment of waste gas
MX2016009325A (es) Metodo para la preparacion de 1-alquil-3-difluorometil-5-fluor-1h- pirazol-4-carbaldehidos y 1-alquil-3-difluorometil-5-fluor-1h-pira zol-4-carboxilatos.
EP3192989A4 (en) Exhaust gas purification system
IN2013MU01113A (sv)
NZ721832A (en) Solid forms of tenofovir
IN2013MU01313A (sv)
WO2014170909A3 (en) Process for pomalidomide